Myopia Pathways May Guide Control - Summary - MDSpire

Myopia Pathways May Guide Control

Review links environmental, optical, and genetic drivers to strategies that may slow eye growth

  • By

  • Andrea Surnit

  • April 13, 2026

  • 3 min

Share

Objective:

To synthesize evidence on how environmental exposure, optical signaling, and genetic susceptibility contribute to myopia development and progression, emphasizing the integration of findings.

Approach:
    Key Findings:
    • Disrupted vision-guided eye growth is a primary driver of myopia progression.
    • Near work and reduced outdoor exposure are significant contributors to myopia.
    • Genetic factors, including variants in the VIPR2 gene, interact with environmental exposures to influence myopia progression.
    • Interventions such as orthokeratology and multifocal lenses significantly reduce axial elongation and myopia progression, with specific percentages noted.
    Interpretation:

    The findings suggest that myopia management should be individualized, considering environmental, optical, and genetic factors for optimal control, highlighting practical implications.

    Limitations:
    • The review included heterogeneous evidence with variability in populations and methodologies, which may affect the generalizability of findings.
    • Conflicting findings regarding accommodative mechanisms necessitate standardized longitudinal research.
    Conclusion:

    An individualized approach to myopia management that combines tailored strategies is essential for effective control, reinforcing the significance of these findings.

    Sources:

Original Source(s)

Myopia Pathways May Guide Control

  • by Andrea Surnit

  • April 13, 2026

Related Content

Beyond the Diopter: Evolving Your Framework for Refractive Surgery Planning

Corneal health, axial length, and long-term ocular preservation are helpful guides for every refractive conversation

Music May Ease Anxiety in Eye Clinics

Background music and multimedia exposure were associated with lower patient-reported anxiety in a quasi-experimental ophthalmology clinic study that used existing clinic audiovisual infrastructure at no additional cost.

Solving the Data Challenge in Ophthalmic AI

At ARVO, Cecilia S. Lee, MD, MS, and Aaron Y. Lee, MD, MSCI, discuss barriers to AI deployment in ophthalmology, including interoperability and model development.